Identification of a new DRB3*02 allelic variant (DRB3*0209) by high-resolution sequence-based typing

Area of Science:

• Immunogenetics
• Molecular Biology
• Human Leukocyte Antigen (HLA) research

Background:

• Accurate Human Leukocyte Antigen (HLA) typing is crucial for transplantation and disease association studies.
• Existing methods may not capture all genetic variations within HLA loci.
• The HLA-DRB3/B4/B5 gene family represents a complex region requiring precise typing techniques.

Purpose of the Study:

• To develop and validate a sequence-based typing method for HLA-DRB3/B4/B5 alleles.
• To identify and characterize novel alleles within the HLA-DRB3 locus.
• To establish a cell line for future research on the newly discovered allele.

Main Methods:

• Development of a novel sequence-based typing method for HLA-DRB3/B4/B5.
• Combination of sequence-based typing with Polymerase Chain Reaction Sequence-Specific Primers (PCR-SSP).
• Isolation, sequencing, and characterization of the new allele, including EBV-transformed cell line generation.

Main Results:

• Identification and official naming of a new HLA-DRB3*0209 allele (GenBank accession number AF148518).
• The DRB3*0209 allele differs from DRB3*0207 by two nucleotide substitutions leading to amino acid changes at codons 51 and 60.
• The new allele was found in North Italian families and its association with the DRB1 locus was identified.

Conclusions:

• The developed sequence-based typing method effectively identifies novel HLA alleles.
• The discovery of DRB3*0209 expands the known HLA allele repertoire.
• An EBV-transformed cell line carrying the DRB3*0209 allele has been established for future research.